🧐 ProPicks AI October update is out now! See which stocks made the listPick Stocks with AI

Procter & Gamble downgrade at Barclays on concerns over organic sales growth path

Published 09/30/2024, 11:03 AM
© Reuters.
PG
-

Investing.com -- Barclays downgraded Procter & Gamble Company (NYSE:PG) from Overweight to Equal Weight on Monday amid concerns over the company's growth trajectory in the next 12 months.

While P&G remains a best-in-class operator in the global consumer staples sector, its heavy exposure to slower-growing or declining markets, particularly China, has become a drag on its overall performance.

According to the report, though P&G’s growth in the U.S. remains strong, contributing to value and volume share gains, these gains are insufficient to offset the struggles in other markets.

China, which accounts for approximately 8-9% of P&G’s sales, remains a particular concern. Despite government stimulus efforts, Barclays is skeptical about a quick recovery, forecasting a 4% decline in Chinese sales for 2025, versus 3% previously. Also, market softness in Asia Pacific and the Middle East is expected to persist.

Analysts also expressed concerns over P&G’s reliance on U.S. growth, which accounts for nearly 50% of its total sales.

"While P&G’s U.S. growth has held up well, other slower growth markets will continue to weigh on overall performance over the next 12 months," they noted.

“We expect P&G's organic sales growth to be ~3%, at the low end of its FY25 guidance, even with the US growing ~4%."

Barclays estimates that P&G’s organic sales growth will fall to around 2.3% in the coming quarters, compared to an average of 4.3% for its competitors.

In terms of valuation, Barclays notes that P&G is trading at a premium—currently around 17% above large-cap U.S. staples and 16% higher than the S&P 500.

The firm believes this premium is no longer justified given the company’s slowing growth outlook. Analysts reiterated their price target of $163, over 5% downside from current levels.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.